CURRENT 2018 Attendees

DOWNLOAD THE BROCHURE
REGISTER NOW

2019 Event Partners

CURRENT 2018 attendING COMPANIES INCLUDE

Please note: A company that is not affiliated with Biotech and Money Ltd. is contacting attendees of our event offering to sell the 2018 Biotech and Money / Medtech and Money attendee list. They are not operating with our approval. Biotech and Money, have not and will not share any data with this company or any other outside party.

02H Ventures InflaRx GmbH
4Bio Capital InHealth Ventures
4D Pharma INKEF Capital
4SC Inmedix Inc
A2VL Innogest
Abingworth Inserm Transfert
Ablynx Instinctif
Absail Capital Interax Biotech
Accelerace Interceptin
Acceleris Capital Inventages
Accelmed Investment fund
Active Needle IO Biotech
Addex Therapeutics IP Group
AdRem Capital IPF Partners
Advent France Biotechnology ISA Pharma
Advent Life Sciences ISIF
Aglaris It-Initiative
Alacrita Ivaldi Capital
Albion Capital J O Hambro Capital Management
Albion Technology & General VCT JAG Shaw Baker
Alderley Park Ventures Jefferies
Allecra Joint Polish Investment Fund
Allecra Pharma Julz & Co.
Allen & Jain Kammeradvokaten
Allen & Overy Karolinska Development
Alsa Holdings Keiretsu Forum
Amadeus Capital Partners Kiadis
Angel Investor King's College London
Antabio Kinled Holding Ltd
Apeiron Biologics AG Kreos Capital
Ardian Kurma Partners
Arecor Laurel Ventures
Arix Bioscience Leerink
Arterial Capital Management LifeArc
Arthurian Life Sciences LIG Biowise
Artios Pharma Limerston Capital
Asarina Pharma Lipocoat
ASIT Biotech Longevity Capital Partners
Astraveus Longwall Ventures
AstraZeneca Lonza
Atelix Ltd Magle Chemoswed
Atlantic Bridge Mangogen
Atriva Therapeutics Marks & Clerk
ATXA Therapeutics Masselos Family Office
AurorA-TT MC-Services
Auspherix McLaren Applied Technologies
Avego Healthcare Capital Medherant
AVM Biotech Medicxi
Balmes Transplantation Medivir
Baxter Medlumics
Beaufort Sciences MedNous
Belsize Asset Management Medtech Insight 
Bioartic Medtronic
BioGeneration Ventures MedXelerator
BioPharm Insight Meneldor
BioProtect Mercia Technologies
Biosana Pharma Merck
Bioscience Managers Merck Ventures BV
BioSeed Capital MetaLinear
Biosignatures Limited Mironid
BioTissue MISSION Therapeutics
Biovotion MOLOGEN AG
Bloomberg Intelligence Momentum Biotech
Blueprint Genetics Monta Biosciences
BNY Mellon Montagu Asset Management
Boehringer Ingelheim Morphosys
Bone Support AB MSD
Bone Therapeutics MSIF
Boston Scientific MTIP
Boston Scientific Ventures Mtonyx
Boult Mubadala
BPI France MXC Capital
Brainwave Bank N+1 Singer
Braster NASDAQ
British Expats in Life Sciences NCL Technology Ventures
BROTHERS & Partners Europe NeoMed
Brown Rudnick NetScientific
Calcivis New Science Fund
Cambridge Angels Newable
Cambridge Enterprise Newcastle Gateshead Initiative
Cambridge Innovation Capital Norgine
Cambridge Medical Robotics Ltd North-East Healthcare
Cambridge Medtech Nova Leah
Cancer Research Technology Novo Seeds
Cantargia Novo Ventures
Capital Cell NOXXON Pharma
Capricorn Ventures Nuritas
Carmell Therapeutics NW Ventures
Carnegie NY Consulting
Catapult Ventures Oisin Biotechnologies Inc
Celgene Olympus Europa
Celixir OMNES Capital
Cell & Gene Therapy Catapult Oncogenx
Cerescom Oncology Venture
Chronos Therapeutics Oncopeptides AB
Circassia Optimum Communications
Citi Bank OrbiMed
Citigate Dewe Rogerson Orca Therapeutics BV
ClearlySo ORI CAPITAL
Clinigen Ostara Biomedical
Clubb Capital Ostoform
CN Bio Innovations Ovusense
CO.DON AG Oxford AHSN
Cocoon Networks Oxford BioMedica
ColeCap Oxford Technology
Confo Therapeutics Oxford University Innovation Ltd.
Consilium Communications Oxon
Cooley Oxstem
Coulter Partners Panakes
Covington Panmure Gordon 
CRB Inverbío Paul Capital
Crescendo Biologics PCI Biotech
Crispr Therapeutics Pentracor
Crossroad Biotech Peppermint Venture Partners GmbH
Curam Capital Perora
Cypralis PhagoMed
DA VOLTERRA Pharmaventures
DDFV Pharmstandard Ventures
Debere Partners PI Trading
Deepbridge Capital Principia SGR
Destiny Pharma Private Investor
Diamond Biopharm Privos Capital
Digital Catapult  Probiodrug AG
DN Capital Proteome Sciences
Downing Qlinea
Droia NV Rainbow Seed Fund
DSM Ventures RBC Capital
Duke Street Re-Pharm
Dyadic Reapplix
Dynasty Biotechnology RedEye
e-Therapeutics Renephra
Earlybird Venture Capital ReNeuron
Edmond de Rothschild Investment Partners Renovos
Eli Lilly and Company RMI Partners
Enesi Pharma Limited Rosetta Capital
Enterprise Ireland Rothschild
Entrust Life Sciences RYSE Asset Management
Entrust People Scancell Holdings
EP Vantage SCRIP Pharma Intelligence
Epi-Endo Pharmaceuticals Selvita SA
EpimAb Biotherapeutics Senzime
Esperante Ventures Seroba Life Sciences
Eternans SGRF
Eurocine Vaccines AB Siemens Healthineers
Euronext Silence Therapeutics
European Investment Fund Simply Capital Partners
Excalibur Group Sixth Element Capital
Exonate SJB Technical Recruitment
EY Sofinnova Partners
F-Prime Capital SOM Biotech
F-star Biotechnology SPARK Impact
Femeda Sphere Medical
Fiagon SPL Pharma
Financial Times SR-One
Flagship Ventures Stent Tek
Flowsion Storm Therapeutics
Folium Science Sugacoll
Fountain Health Partners Summit plc
FreeMind Sunstone Capital
Fresenius Medical Care Ventures GmbH SV Health Investors
FTI Consulting SwabTech
Future Care Capital Syncona Ltd
Galapagos NV Syndicate Room
Galecto Biotech Talentmark
Genentech Partnering Talix Therapeutics
GIC Tassi & Co.
Gilde Healthcare TAXIS Pharmaceuticals, Inc.
GIMV The Capital Partnership
GJE LLP the Side by Side Partnership
Glide Technologies The University of Manchester Intellectual Property Ltd (UMIP)
Global Core Medical Topas Therapeutics GmbH
Goldman Sachs Touchstone Innovations
Goodwin Procter TPBioVentures Ltd
Graphite Capital Trilantic Europe
GSK Trinity Delta
Hadasit Medical Research Services and Development Tusk Therapeutics
Hadean Ventures TVM Capital Life Science
Haemair TYG-Oncology
Hansa Medical AB UCB Pharma
Harbert Management UCB Ventures
Haseltine Lake Universitat Autònoma de Barcelona 
Health Equity Consulting University of Cambridge
Health Ventures University of Dundee 
HealthCap University of Edinburgh
Healthcare Royalty Partners University of Manchester
Heat Biologics University of Southampton
Heptares Therapeutics ValiRx
Herantis Ventac Partners
Hermes Partners Venture Founders
Hi-Tech Gruenderfunds Verona Pharma
Hookipa Biotech Vinge
Horizon Discovery Group Plc Vita
Idogen AB VIVET Therapeutics
Ignite Capital Partners, Inc. VolitionRx
Illumina Ventures Waimangu Ventures
Image Analysis Group (IAG) Wharton Alumni Angel Network
Immersive Rehab Wharton Asset Management
Immunicum White & Case
Imperial Innovations WideCells 
Imperium Global Wren Capital
Inceptua S.A. Zilico
Independent Investor ZOLL Medical, an Asahi Kasei Group Company
Industrifonden Zonda Partners
  Zukunftsfonds Heilbronn